Page 2 - Amrn News Today

MELBOURNE, Australia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated...

JPMorgan Chase & Co. reiterated their underweight rating on shares of Amarin (NASDAQ:AMRN – Free Report) in a report published on Monday morning, Benzinga reports. A number of other analysts have also commented on the company. Jefferies Financial Group lowered Amarin from a buy rating to a hold rating and cut their price target for […]

MELBOURNE, Australia, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated...

Amarin (NASDAQ:AMRN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, profitability, earnings, dividends and valuation. Volatility and Risk Amarin has a beta of 1.87, indicating […]

Amarin (NASDAQ:AMRN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk. Valuation and Earnings This table compares Amarin and Roche’s top-line […]

StockNews.com assumed coverage on shares of Amarin (NASDAQ:AMRN – Free Report) in a report issued on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. AMRN has been the subject of a number of other research reports. Northland Securities reduced their price objective on Amarin from $2.00 to $1.25 in a report […]

The stock of Amarin Corporation plc (NASDAQ: AMRN) has increased by 0.99 when compared to last closing price of 1.01.Despite this, the company has seen a gain of 0.99% in its stock price over the last five trading days. GlobeNewsWire reported 2023-09-12 that DUBLIN, Ireland and BRIDGEWATER, N.J., Se

13D Management LLC lifted its position in Amarin Co. plc (NASDAQ:AMRN – Free Report) by 90.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,166,900 shares of the biopharmaceutical company’s stock after purchasing an additional 1,980,000 shares during the […]

StockNews.com started coverage on shares of Amarin (NASDAQ:AMRN – Free Report) in a research note published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Several other brokerages have also recently weighed in on AMRN. Northland Securities decreased their target price on Amarin from $2.00 to $1.25 in a research […]

Amarin Co. plc (NASDAQ:AMRN – Free Report) – Research analysts at Northland Capmk cut their Q2 2023 earnings per share (EPS) estimates for Amarin in a report released on Wednesday, July 19th. Northland Capmk analyst C. Byrnes now expects that the biopharmaceutical company will post earnings of ($0.06) per share for the quarter, down from […]